Related Experiment Videos
[Phase II therapeutic trials in Cancerology: what's new? For a better multicenter and multidisciplinary cooperation]
Gastroenterologie Clinique Et Biologique
|January 1, 1992
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Circulating innate immune markers and outcomes in treatment-naïve advanced non-small cell lung cancer patients.
European journal of cancer (Oxford, England : 1990)·2019
[New developments in the management of nasopharyngeal carcinoma].
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2018
Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?
Lung cancer (Amsterdam, Netherlands)·2014
[Treatment of chronic hepatitis B: adherence and safety].
Gastroenterologie clinique et biologique·2010
[Long-term therapy for chronic hepatitis B in HIV co-infected patients].
Gastroenterologie clinique et biologique·2010
[Analogs combination therapy in chronic hepatitis B: when and how?].
Gastroenterologie clinique et biologique·2010
[HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
Gastroenterologie clinique et biologique·2010
[HBsAg quantification: virological significance].
Gastroenterologie clinique et biologique·2010
[Influence of treatment on long-term evolution of chronic hepatitis B].
Gastroenterologie clinique et biologique·2010